Phase 3 Retatrutide trials currently underway will address these gaps with larger, longer studies before FDA submission
Frequently Asked Questions About Tirzepatide Vs Retatrutide Which is better for weight loss, tirzepatide or retatrutide
The SELECT trial, which evaluated semaglutide 2.4 mg against placebo for cardiovascular outcomes in patients with overweight and obesity without type 2 diabetes, showed significant decreases in total cholesterol, LDL-C, and triglycerides and an increase in HDL-C at 39.8 months [48]
Retrieved from SingleCare-f
Last but not least, by reducing the dose and avoiding systemic distribution, nasal delivery of GLP-1 drugs should alleviate gastrointestinal and other adverse events, offering a promising approach for maximizing the therapeutic effects GLP-1 drugs with potentially increased compliance and safety
On the one hand, you could be experiencing diarrhea